Literature DB >> 28935696

A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility.

Erin C Peckham-Gregory1,2, Rikhia Chakraborty1,2, Michael E Scheurer1,2, John W Belmont3,4, Harshal Abhyankar1, Amel G Sengal1, Brooks P Scull1, Olive Eckstein1, Daniel J Zinn1, Louisa Mayer1,2, Albert Shih1, Miriam Merad5, D Williams Parsons1,2,3, Kenneth L McClain1,2, Philip J Lupo1,2, Carl E Allen1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28935696      PMCID： PMC5691246          DOI： 10.1182/blood-2017-08-800565

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  27 in total

1.  The NCBI dbGaP database of genotypes and phenotypes.

Authors:  Matthew D Mailman; Michael Feolo; Yumi Jin; Masato Kimura; Kimberly Tryka; Rinat Bagoutdinov; Luning Hao; Anne Kiang; Justin Paschall; Lon Phan; Natalia Popova; Stephanie Pretel; Lora Ziyabari; Moira Lee; Yu Shao; Zhen Y Wang; Karl Sirotkin; Minghong Ward; Michael Kholodov; Kerry Zbicz; Jeffrey Beck; Michael Kimelman; Sergey Shevelev; Don Preuss; Eugene Yaschenko; Alan Graeff; James Ostell; Stephen T Sherry
Journal:  Nat Genet       Date:  2007-10       Impact factor: 38.330

2.  A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting.

Authors:  C R Weinberg; A J Wilcox; R T Lie
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

3.  Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis.

Authors:  Karina Braga Ribeiro; Barbara Degar; Célia Beatriz Gianotti Antoneli; Barrett Rollins; Carlos Rodriguez-Galindo
Journal:  Pediatr Blood Cancer       Date:  2015-01-13       Impact factor: 3.167

4.  ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

Authors:  Heng Xu; Cheng Cheng; Meenakshi Devidas; Deqing Pei; Yiping Fan; Wenjian Yang; Geoff Neale; Paul Scheet; Esteban G Burchard; Dara G Torgerson; Celeste Eng; Michael Dean; Frederico Antillon; Naomi J Winick; Paul L Martin; Cheryl L Willman; Bruce M Camitta; Gregory H Reaman; William L Carroll; Mignon Loh; William E Evans; Ching-Hon Pui; Stephen P Hunger; Mary V Relling; Jun J Yang
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

5.  Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients.

Authors:  Harry H Yoon; Qian Shi; Steven R Alberts; Richard M Goldberg; Stephen N Thibodeau; Daniel J Sargent; Frank A Sinicrope
Journal:  J Natl Cancer Inst       Date:  2015-07-09       Impact factor: 13.506

6.  FTO Obesity Variant Circuitry and Adipocyte Browning in Humans.

Authors:  Melina Claussnitzer; Simon N Dankel; Kyoung-Han Kim; Gerald Quon; Wouter Meuleman; Christine Haugen; Viktoria Glunk; Isabel S Sousa; Jacqueline L Beaudry; Vijitha Puviindran; Nezar A Abdennur; Jannel Liu; Per-Arne Svensson; Yi-Hsiang Hsu; Daniel J Drucker; Gunnar Mellgren; Chi-Chung Hui; Hans Hauner; Manolis Kellis
Journal:  N Engl J Med       Date:  2015-08-19       Impact factor: 91.245

7.  PREMIM and EMIM: tools for estimation of maternal, imprinting and interaction effects using multinomial modelling.

Authors:  Richard Howey; Heather J Cordell
Journal:  BMC Bioinformatics       Date:  2012-06-27       Impact factor: 3.169

8.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Authors:  Marie-Luise Berres; Karen Phaik Har Lim; Tricia Peters; Jeremy Price; Hitoshi Takizawa; Hélène Salmon; Juliana Idoyaga; Albert Ruzo; Philip J Lupo; M John Hicks; Albert Shih; Stephen J Simko; Harshal Abhyankar; Rikhia Chakraborty; Marylene Leboeuf; Monique Beltrão; Sérgio A Lira; Kenneth M Heym; Venetia Bigley; Matthew Collin; Markus G Manz; Kenneth McClain; Miriam Merad; Carl E Allen
Journal:  J Exp Med       Date:  2014-03-17       Impact factor: 14.307

9.  Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles.

Authors:  Andrew T Timberlake; Jungmin Choi; Samir Zaidi; Qiongshi Lu; Carol Nelson-Williams; Eric D Brooks; Kaya Bilguvar; Irina Tikhonova; Shrikant Mane; Jenny F Yang; Rajendra Sawh-Martinez; Sarah Persing; Elizabeth G Zellner; Erin Loring; Carolyn Chuang; Amy Galm; Peter W Hashim; Derek M Steinbacher; Michael L DiLuna; Charles C Duncan; Kevin A Pelphrey; Hongyu Zhao; John A Persing; Richard P Lifton
Journal:  Elife       Date:  2016-09-08       Impact factor: 8.140

10.  Population substructure and control selection in genome-wide association studies.

Authors:  Kai Yu; Zhaoming Wang; Qizhai Li; Sholom Wacholder; David J Hunter; Robert N Hoover; Stephen Chanock; Gilles Thomas
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240
View more
  5 in total

Review 1.  Langerhans-Cell Histiocytosis.

Authors:  Carl E Allen; Miriam Merad; Kenneth L McClain
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

Review 2.  Histiocytic disorders.

Authors:  Kenneth L McClain; Camille Bigenwald; Matthew Collin; Julien Haroche; Rebecca A Marsh; Miriam Merad; Jennifer Picarsic; Karina B Ribeiro; Carl E Allen
Journal:  Nat Rev Dis Primers       Date:  2021-10-07       Impact factor: 65.038

3.  The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among Hispanics.

Authors:  Erin C Peckham-Gregory; Kenneth L McClain; Carl E Allen; Michael E Scheurer; Philip J Lupo
Journal:  Ann Epidemiol       Date:  2018-04-17       Impact factor: 3.797

Review 4.  Histiocytosis.

Authors:  Jean-François Emile; Fleur Cohen-Aubart; Matthew Collin; Sylvie Fraitag; Ahmed Idbaih; Omar Abdel-Wahab; Barrett J Rollins; Jean Donadieu; Julien Haroche
Journal:  Lancet       Date:  2021-04-23       Impact factor: 202.731

Review 5.  Langerhans cell histiocytosis: Version 2021.

Authors:  Nitya Gulati; Carl E Allen
Journal:  Hematol Oncol       Date:  2021-06       Impact factor: 4.850
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.